PET imaging of garbage protein in Alzheimer's disease: does it require reappraisal of brain PET analysis?

Eur J Nucl Med Mol Imaging. 2014 May;41(5):813-5. doi: 10.1007/s00259-014-2740-8.

Author

Serge Goldman¹

Affiliation

¹ PET/Biomedical Cyclotron Unit - Department of Nuclear Medicine, ULB-Hôpital Erasme, and Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, 808 Route de Lennik, Brussels, Belgium, sgoldman@ulb.ac.be.

PMID: 24615470
DOI: 10.1007/s00259-014-2740-8

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Alzheimer Disease / diagnostic imaging*
Aniline Compounds*
Female
Humans
Male
Quinolines*
Radionuclide Imaging
Radiopharmaceuticals*
tau Proteins / metabolism*

Substances

2-(4-aminophenyl)-6-(2-fluoroethoxy)quinoline
Aniline Compounds
MAPT protein, human
Quinolines
Radiopharmaceuticals
tau Proteins